A Study of the ReCor Medical Paradise System in Clinical Hypertension

Running, not enrolling · Not applicable · Has a placebo group

Conditions studied: Hypertension, Vascular Diseases

In brief

RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.

Key facts

Study ID
NCT02649426
Run by
ReCor Medical, Inc.
People needed
282
Starts
2016-03-01
Expected to finish
2027-05-01
Last updated by the study team
2026-04-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.